| European Case Law Identifier: | ECLI:EP:BA:1998:T079494.19980917 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 17 September 1998 | ||||||||
| Case number: | T 0794/94 | ||||||||
| Application number: | 78300596.0 | ||||||||
| IPC class: | C12N 15/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | B | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Plasmid for transforming bacterial host to render it capable of polypeptide expression | ||||||||
| Applicant name: | Genentech, Inc. | ||||||||
| Opponent name: | Roussel Uclaf Eli Lilly and Company Biogen Inc. Novartis AG Patent and Trademark Dept. Boehringer Mannheim GmbH Patentabteilung Gist-brocades NV Hoechst Aktiengesellschaft |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request and first auxiliary request - not admitted into proceedings Second auxiliary request - inventive step (no) |
||||||||
| Catchwords: |
Criteria for admission of late filed requests during oral proceedings |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940794eu1.html
Date retrieved: 17 May 2021